A sign for the Food And Drug Administration is seen outside of the headquarters. -- coverage from STAT
Sarah Silbiger/Getty Images

By Lizzy Lawrence

March 18, 2026

FDA Reporter

Lizzy Lawrence

[email protected]

Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53.

WASHINGTON — The Food and Drug Administration official in charge of reviewing infectious disease products is leaving the agency, according to an email viewed by STAT. 

Adam Sherwat, the director of the Office of Infectious Diseases in the FDA’s Center for Drug Evaluation and Research, told colleagues on Wednesday that his last day at the agency will be April 4. “I have been extremely fortunate to work with and learn from colleagues who are dedicated to improving public health and who are guided by integrity, impartiality, and intellect,” he wrote. 

Advertisement

Sherwat did not respond to a request for comment. It’s not clear why he is leaving the agency.

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $399/year

$30 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe
,
Submit a correction requestReprints

  1. Lizzy Lawrence

    FDA Reporter

    Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53.